Mavefund EN
DaVita HealthCare Partners Inc logo

DaVita HealthCare Partners Inc

DVA
Letzter Kurs (USD) US$176.40
Marktkapitalisierung (USD) US$15.7b
Kursänderung 12 Monate 28.05%
Loading the 12-month Mave Thesis and 1-month news signal

Branchen- und Sektorvergleich sowie weitere Research-Alternativen

Vergleich ansehen
Universal Health Services IncUHS Vergleich CHEMED CORPCHE Vergleich Tenet HealthcareTHC Vergleich Zoetis IncZTS Vergleich
Überblick Ergebnisbericht Kursverlauf Nachrichten Wettbewerber Gewinn je Aktie Eigenkapitalrendite Nettomarge Aktienrückkäufe Verschuldung Finanzberichte Finanzkennzahlen
Start Heute Aktien Watchlist

DaVita HealthCare Partners Inc Überblick

Branche: Medical Care Facilities

Sektor: Healthcare

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado. DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodial

Research-Überblick

Letztes Berichtsdatum 2026-08-04

Diese Mavefund-Research-Seite bündelt geprüfte Informationen zu DaVita HealthCare Partners Inc (DVA): Unternehmensprofil, Kursverlauf, verknüpfte Primärquellen, verfügbare Finanzberichte, Research-Signale und zu prüfende Risiken.

Börsennotierung
DVA · NYSE · MIC XNYS
Land
United States
Handelswährung
USD
Branche
Medical Care Facilities
Finanzdaten
Jahres- und Zwischenabschlüsse verfügbar
Letzte Primärquelle
SEC EDGAR · veröffentlicht 2026-08-04
Primärquellen

Die Abdeckung wird automatisch aktualisiert und erst nach einer Datenintegritätsprüfung veröffentlicht. Nur Research-Unterstützung; keine persönliche Anlageberatung.

Mavefund ordnet die verfügbaren Fundamentaldaten, Bewertungskennzahlen und Risikofaktoren von DaVita HealthCare Partners Inc für einen nachvollziehbaren Research-Prozess ein.

Score

Veröffentlichte Ergebnisse

Was das Unternehmen berichtet hat – mit kompakter Quellenangabe.

Veröffentlicht Aug 04, 2026

Quarterly result summary

Revenue was $3.6B (reported); EPS was $4.02 (reported).

Revenue $3.6B reported
EPS $4.02 reported
Operating income $579M reported
Net income $265M +34% YoY

Was sich verändert hat

  • Revenue reported to $3.6B; EPS reported to $4.02.
  • Capital return update: free cash flow $256M.
  • Net income +34% YoY to $265M.

Guidance / outlook

No formal outlook was extracted from this filing excerpt. Open the source document to review full management commentary.

Earnings release Bericht öffnen

Source: SEC EDGAR company-filed earnings materials. Dates and source identifiers are retained for verification; review the original filing before relying on extracted report details.

Weitere aktuelle Ergebnisunterlagen
SEC filing 8-K Aug 04, 2026 SEC filing 10-Q Aug 04, 2026 SEC filing 10-Q May 05, 2026 SEC filing 8-K May 05, 2026 Earnings release Earnings release May 05, 2026 SEC filing 10-K Feb 11, 2026 SEC filing 8-K Feb 02, 2026 Earnings release Earnings release Feb 02, 2026 SEC filing 10-Q Oct 29, 2025 SEC filing 8-K Oct 29, 2025 Earnings release Earnings release Oct 29, 2025

Geprüfte Signal-Evidenz

Aktuelle Nachrichten

Unternehmensrelevante Artikel aus Quellen, die die Relevanz- und Zuverlässigkeitsprüfung des Mave Signals bestehen.

Gewinn je Aktie

Score 4.00/5
DaVita HealthCare Partners Inc boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
In Medical Care Facilities industry , Universal Health Services Inc , CHEMED CORP , Tenet Healthcare are companies with high ratings.

Eigenkapitalrendite

Score 3.81/5
DaVita HealthCare Partners Inc stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
DaVita Healt... DVA US$15.7b
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Agilent Tech... A US$37.9b

Nettomarge

Score 4.61/5
DaVita HealthCare Partners Inc commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
DaVita Healt... DVA US$15.7b
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Agilent Tech... A US$37.9b

Aktienrückkäufe

In Medical Care Facilities industry , Universal Health Services Inc , CHEMED CORP , Tenet Healthcare are companies with high ratings.

Verschuldung

Score 1.11/5
DaVita HealthCare Partners Inc registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc have achieved high scores.
DaVita Healt... DVA US$15.7b
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Agilent Tech... A US$37.9b

Finanzberichte

Vom Unternehmen veröffentlichte Berichtsdaten, strukturiert und mit der Originalquelle verknüpft.

Berichtswährung
Geprüfte, quellenverknüpfte Finanzberichte werden geladen, sobald dieser Abschnitt sichtbar wird.

Quellendetails werden mit den Berichtsdaten geladen. Die Werte sind standardisierte Unternehmensangaben zur Research-Unterstützung, keine persönliche Anlageberatung.

Finanzkennzahlen

Jährlich Quartalsweise

Finanzen
Profitabilität
Wachstum
Cashflow
Finanzielle Stabilität
Effizienzkennzahlen

DaVita HealthCare Partners Inc logo

DaVita HealthCare Partners Inc

US$176.40

US$182.81

+0.8% vs price

US$15.7b

0.71%

28.05%